Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • May 2020
  • Global
  • 350 Pages
  • No of Tables: 208
  • No of Figures: 68

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts and Others), Target (Trabecular Meshwork Suprachoroidal Space Subconjunctival Filtration and Reducing Aqueous Production), Surgery Type (Glaucoma in Conjunction with Cataract  and Stand-Alone Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and  rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa) Industry Trends & Forecast to 2027      

Micro Invasive Glaucoma Surgery (MIGS) Devices MarketMarket Analysis and Insights: Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market 

Micro invasive glaucoma surgery (MIGS) Devices Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 31.7% in the forecast period of 2020 to 2027 and is expected to reach USD 3,203.1 million by 2027. Rising incidence of glaucoma across the world, increase in the geriatric population are the major drivers which propelled the demand of the market in the forecast period.

MIGS stands for micro invasive glaucoma surgery which is useful in the treatment of glaucoma. It is breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternate to the medications given earlier and it also prevents the complications of conventional surgery type. These procedures are used to lower the intra ocular pressure of the eye to prevent the damage of optic nerve. These procedures are safer and have a very rapid recovery time as compared to the conventional surgery type

MIGS devices demand has increased as compared to the precise year with rapid transition from glaucoma medication to minimally invasive glaucoma surgeries along with introduction of technological advanced product. In addition demand of MIGS devices has increased because of government initiatives to increase awareness about prevention of blindness. Further inadequate reimbursement scenario is expected to restraint the usage of MIGS devices and is expected to slow down the growth of the MIGS devices market in the forecasted period.  

The micro invasive glaucoma surgery (MIGS) devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.  

Micro Invasive Glaucoma Surgery (MIGS) Devices MarketGlobal Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope and Market Size

 Micro invasive glaucoma surgery (MIGS) devices market is segmented on the basis of product, target, surgery type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the market is segmented into MIGS stents, MIGS shunts and others. MIGS Stents is dominating the market due to the high adoption of MIGS stents in micro invasive glaucoma surgery (MIGS) for lowering IOP in difficult-to-treat patients. Further a variety of new glaucoma micro-stents are being manufactured with the usage of various materials.
  •  On the basis of target, the market is segmented into trabecular meshwork suprachoroidal space subconjunctival filtration and reducing aqueous production. Trabecular meshwork segment is dominating the market as various products available in the market is targeting Trabecular meshwork for the glaucoma treatment as trabecular meshwork is one of the main structures of the drainage angle and plays a very crucial role in the drainage of aqueous humor. In the Eye majority of fluid draining out of the eye is via the trabecular meshwork.
  • On the basis of surgery type, the market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma. Glaucoma in conjunction with cataract segment is dominating the market due to increasing adoption of micro invasive glaucoma surgery (MIGS) procedure conjunction with cataract in the developed and developing countries. 
  • On the basis of end user, the market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS) and othersHospital outpatient departments (HOPD) segment is dominating the market as the micro invasive glaucoma surgery (MIGS) procedure is an outpatient surgery that normally takes less than 30 minutes and hospital outpatient departments (HOPD) are one of the first contact point and most trustable option for the patients in various countries. 
  • On the basis of distribution channel, the market is segmented into direct tender and retail sales. Direct tender segment is dominating the market as most of the hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS) are preferring direct tender for the seeking the benefits of bulk buying, discounts and easily availability of products.

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Micro invasive Glaucoma Surgery (MIGS) Devices Market Country Level Analysis

Micro invasive glaucoma surgery (MIGS) devices market is analysed and market size information is provided by product, target, surgery type, end user and distribution channel.

The countries covered in the micro invasive glaucoma surgery (MIGS) devices market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa.   

North America is dominating the market due to the high adoption of micro invasive glaucoma surgery (MIGS) devices for the treatment of glaucoma in the region and North America due to increasing number of research and development along with clinical trials in the region. U.S is dominating in the market and leading the growth in the North America market due to increasing high adoption of micro invasive glaucoma surgery (MIGS) for lowering IOP in difficult-to-treat patients. China is dominating Asia-Pacific market due to rising incidence of glaucoma across and increasing government initiatives to increase awareness about prevention of blindness and also increasing awareness regarding treatment of glaucoma with micro invasive surgical procedures. Germany is dominating the European market with the increasing growing popularity of outpatient surgeries for treatment of glaucoma and increasing geriatric population in the region. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Devices is Creating New Opportunities for Players in the Micro Invasive Glaucoma Surgery (MIGS) Devices Market 

 Micro invasive glaucoma surgery (MIGS) devices market also provides you with detailed market analysis for every country growth in particular industry with micro invasive glaucoma surgery (MIGS) devices sales, impact of advancement in the micro invasive glaucoma surgery (MIGS) devices and changes in regulatory scenarios with their support for the micro invasive glaucoma surgery (MIGS) devices market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share Analysis

 Micro Invasive glaucoma surgery (MIGS) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to micro invasive glaucoma surgery (MIGS) devices market.

The major players covered in the report are Glaukos Corporation, Ivantis Inc., Allergan, Ellex, Alcon, BVI, Johnson and Johnson Surgical Vision Inc. and Johnson and Johnson Vision Care Inc. (A subsidiary of Johnson and Johnson Inc.), Microsurgical technology, Molteno Ophthalmic Ltd. ,New world Medical ,Santen Pharmaceutical, Sight Scientific  among others. among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the micro invasive glaucoma surgery (MIGS) devices market.

For instance,

  • In November, 2019 Glaukos Corporation stated that it has taken over Avedro, Inc., which also works in the development of products for corneal health. This acquisition has led to widening of product portfolio This led to an enhancement in the revenue of the company.
  • In July, 2019 MicroSurgical Technology (MST), in collaboration with glaucoma and cataract surgeon Ike Ahmed, MD, has launched a product known as MST 19-gauge Ahmed Micro Stent Cutter.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the Micro Invasive glaucoma surgery (MIGS) devices market which also provides the benefit for organisation to improve their offering for glaucoma surgery devices market.

Customization Available : Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040

TABLE 2 NUMBER OF OPHTHALMOLOGISTS / MILLION POPULATIONS

TABLE 3 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 4 GLOBAL MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 GLOBAL MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 8 GLOBAL TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 GLOBAL SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 GLOBAL SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 GLOBAL REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 13 GLOBAL GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 GLOBAL STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 16 GLOBAL HOSPITAL OUTPATIENT DEPARTMENTS (HOPD) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 GLOBAL OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 GLOBAL AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 21 GLOBAL DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 GLOBAL RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 27 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 30 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 31 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 32 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 33 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 34 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 35 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 36 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 37 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 38 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 39 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 40 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 41 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 42 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 43 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 44 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 45 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 46 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 47 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 48 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 49 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 50 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 51 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 52 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 53 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 54 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 55 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 56 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 57 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 61 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 62 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 63 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 64 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 65 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 66 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 67 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 68 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 69 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 70 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 71 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 72 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 73 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 74 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 76 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 77 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 78 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 79 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 80 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 81 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 82 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 83 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 84 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 85 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 86 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 87 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 88 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 89 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 90 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 91 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 95 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 96 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 97 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 98 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 99 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 100 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 101 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 102 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 103 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 104 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 105 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 106 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 107 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 108 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 109 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 110 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 111 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 112 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 113 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 114 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 115 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 116 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 117 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 118 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 119 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 120 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 121 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 122 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 123 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 124 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 125 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 126 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 127 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 128 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 129 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 130 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 131 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 132 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 133 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 134 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 135 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 136 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 137 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 138 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 139 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 140 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 141 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 142 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 143 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 144 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 145 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 146 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 147 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 148 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 149 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 150 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 151 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 152 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 153 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 154 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 155 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 156 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 157 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 158 REST OF ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 159 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 160 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 161 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 162 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 163 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 164 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 165 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 166 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 167 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 168 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 169 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 170 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 171 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 172 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 173 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 174 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 175 REST OF SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 176 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 177 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 178 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 179 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 180 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 181 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 182 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 183 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 184 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 185 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 186 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 187 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 188 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 189 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 190 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 191 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 192 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 193 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 194 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 195 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 196 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 197 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 198 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 199 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 200 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 201 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 202 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 203 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 204 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 205 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 206 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 207 REST OF MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 208 LOCATION OF MANUFACTURING PLANTS OF ALLERGAN

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19